Back to search

Article

HDAC6 inhibition to treat heart failure with preserved ejection fraction

2023-06-16

Abstract excerpt

Heart failure with preserved ejection fraction (HFpEF) is a prevalent health condition associated with high morbidity and mortality, but currently, there are few effective therapies. Our previous research showed that inhibiting histone deacetylase 6 (HDAC6) had a beneficial effect on a genetic cardiomyopathy model. The overlapping underlying mechanisms involving inflammation and metabolism between cardiomyopathy a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
16587087-e6b6-5a6f-8e83-dc9b8b5121e5
DOI
10.21203/rs.3.rs-2997460/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
HDAC6 inhibition to treat heart failure with preserved ejection fractionDOI 10.21203/rs.3.rs-2997460/v1
Select a neighboring publication to make it the new centre.